Enhancing melanoma treatment with resveratrol

Journal of Surgical Research

Volumn 172, Issue 1, 2012, Pages 109-115

  Osmond, Gregory W ^a,b   Augustine, Christina K ^a,c   Zipfel, Patricia A ^a,c   Padussis, James ^a   Tyler, Douglas S ^a,c  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY   (United States)

^c DURHAM VA MEDICAL CENTER   (United States)

Author keywords

melanoma; melphalan; resveratrol; temozolomide

Indexed keywords

RESVERATROL; TEMOZOLOMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER THERAPY; CELL ASSAY; CELL VIABILITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG CYTOTOXICITY; DRUG EXPOSURE; DRUG HALF LIFE; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; IN VIVO STUDY; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TREATMENT RESPONSE; TUMOR VOLUME; TUMOR XENOGRAFT; WESTERN BLOTTING;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE; CELL LINE, TUMOR; CHEMOTHERAPY, ADJUVANT; DACARBAZINE; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; HUMANS; MELANOMA; MELPHALAN; MICE; MICE, NUDE; MICE, SCID; SKIN NEOPLASMS; STILBENES; TREATMENT OUTCOME; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 82955194712     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2010.07.033     Document Type: Article

References (38)

1. D.S. Rigel, R.J. Friedman, and A.W. Kopf The incidence of malignant melanoma in the United States: Issues as we approach the 21st century J Am Acad Dermatol 34 1996 839
2. A.M. Eggermont, and J.M. Kirkwood Re-evaluating the role of dacarbazine in metastatic melanoma: What have we learned in 30 years? Eur J Cancer 40 2004 1825
3. J.B. Meric, O. Rixe, and D. Khayat Metastatic malignant melanoma Drugs Today (Barc) 39 Suppl C 2003 17
4. M. Jang, L. Cai, and G.O. Udeani Cancer chemopreventive activity of resveratrol, a natural product derived from grapes Science 275 1997 218
5. S. Bradamante, L. Barenghi, and A. Villa Cardiovascular protective effects of resveratrol Cardiovasc Drug Rev 22 2004 169
6. K. Sinha, G. Chaudhary, and Y.K. Gupta Protective effect of resveratrol against oxidative stress in middle cereral artery occlusion model of stroke in rats Life Sci 71 2002 655
7. Q. Wang, J. Xu, and G.E. Rottinghaus Resveratrol protects against global cerebral ischemic injury in gerbils Brain Res 958 2002 439
8. J.A. Baur, and D.A. Sinclair Therapeutic potential of resveratrol: The in vivo evidence Nat Rev Drug Discov 5 2006 493
9. S. Yang, K. Irani, and S.E. Heffron Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE/Ref-1) in human melanoma and identification of the therapeutic potential of resveratrol as an APE/Ref-1 inhibitor Mol Cancer Ther 4 2005 1923
10. D. Delmas, C. Rébé, and O. Micheau Redistribution of CD95, DR4 and DR5 in rafts accounts for the synergistic toxicity of resveratrol and death receptor ligands in colon carcinoma cells Oncogene 23 2004 8979
11. J. Duraj, J. Bodo, and M. Sulikova Diverse resveratrol sensitization to apoptosis induced by anticancer drugs in sensitive and resistant leukemia cells Neoplasma 53 2006 384
12. S. Fulda, and K.M. Debatin Sensitization for anticancer drug-induced apoptosis by the chemopreventive agent resveratrol Oncogene 23 2004 6702
13. A.R. Jazirehi, and B. Bonavida Resveratrol modifies the expression of apoptotic regulatory proteins and sensitizes non-Hodgkin's lymphoma and multiple myeloma cell lines to paclitaxel-induced apoptosis Mol Cancer Ther 3 2004 71
14. S. Fulda, and K.M. Debatin Sensitization for tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by the chemopreventive agent resveratrol Cancer Res 64 2004 337
15. Y. Yoshimoto, C.K. Augustine, and J.S. Yoo Defining regional infusion treatment strategies for extremity melanoma: Comparative analysis of melphalan and temozolomide as regional chemotherapeutic agents Mol Cancer Ther 6 2007 1492
16. T. Mossman Rapid colorimetric assay for cellular growth and survivals: Application to proliferation and cytotoxicity assays J Immunol Methods 65 1983 55
17. C.K. Augustine, J.S. Yoo, and A. Potti Genomic and molecular profiling predicts response to temozolomide in melanoma Clin Cancer Res 2009 15
18. R.M. Niles, C.P. Cook, and G.G. Meadows Resveratrol is rapidly metabolized in athymic (nu/nu) mice and does not inhibit human melanoma xenograft tumor growth J Nutr 136 2006 2542
19. P. Ferrer, M. Asensi, and R. Segarra Association between pterostilbene and quercetin inhibits metastatic activity of B16 melanoma Neoplasia 7 2005 37
20. T. Walle, F. Hsieh, and M.H. DeLegge High absorption but very low bioavailability of oral resveratrol in humans Drug Metab Dispos 32 2004 1377
21. M.V. Clement, J.L. Hirpara, and S.H. Chawdhury Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells Blood 92 1998 996
22. O. Micheau, E. Solary, and A. Hammann Sensitization of cancer cells treated with cytotoxic drugs to fas-mediated cytotoxicity J Natl Cancer Inst 89 1997 783
23. M. Muzio, A.M. Chinnaiyan, and F.C. Kischkel FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex Cell 85 1996 817
24. A. Rensing-Ehl, K. Frei, and R. Flury Local Fas/APO-1 (CD95) ligand-mediated tumor cell killing in vivo Eur J Immunol 25 1995 2253
25. C. Huang, W.Y. Ma, and A. Goranson Resveratrol suppresses cell transformation and induces apoptosis through a p53-dependent pathway Carcinogenesis 20 1999 237
26. J. Lu, C.H. Ho, and G. Ghai Resveratrol analog, 3,4,5,4'- tetrahydroxystilbene, differentially induces pro-apoptotic p53/Bax gene expression and inhibits the growth of transformed cells but not their normal counterparts Carcinogenesis 22 2001 321
27. M. Mahyar-Roemer, A. Katsen, and P. Mestres Resveratrol induces colon tumor cell apoptosis independently of p53 and precede by epithelial differentiation, mitochondrial proliferation and membrane potential collapse Int J Cancer 94 2001 615
28. F. Bunz, A. Dutriaux, and C. Lengauer Requirement for p53 and p21 to sustain G2 arrest after DNA damage Science 282 1998 1497
29. T.C. Hsieh, G. Juan, and Z. Darzynkiewicz Resveratrol increases nitric oxide synthase, induces accumulation of p53 and p21(WAF1/CIP1), and suppresses cultured bovine pulmonary artery endothelial cell proliferation by perturbing progression through S and G2 Cancer Res 59 1999 2596
30. S.K. Manna, A. Mukhopadhyay, and B.B. Aggarwal Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-κ B, activator protein-1, and apoptosis: Potential role of reactive oxygen intermediates and lipid peroxidation J Immunol 164 2000 6509
31. Stewart JR, McConkey DJ, O'Brian CA. Proceedings of the American Association of Cancer Research 2002;43:854.
32. R.A. Baxter Anti-aging properties of resveratrol: Review and report of a potent new antioxidant skin care formulation J Cosmet Dermatol 7 2008 2
33. A.W. Opipari Jr., L. Tan, and A.E. Boitano Resveratrol-induced autophagocytosis in ovarian cancer cells Cancer Res 64 2004 696
34. K.T. Howitz, K.J. Bitterman, and H.Y. Cohen Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan Nature 425 2003 191
35. L. Buryanovskyy, Y. Fu, and M. Boyd Crystal structure of quinone reductase 2 in complex with resveratrol Biochemistry 43 2004 11417
36. W. Zhang, and M.L. Go Quinone reductase induction activity of methoxylated analogues of resveratrol Eur J Med Chem 42 2007 841
37. A. Gosslau, S. Pabbaraja, and S. Knapp Trans- and cis-stilbene polyphenols induced rapid perinuclear mitochondrial clustering and p53-independent apoptosis in cancer cells but not normal cells Eur J Pharmacol 587 2008 25
38. A.K. Joe, H. Liu, and M. Suzui Resveratrol induces growth inhibition, S-phase arrest, apoptosis, and changes in biomarker expression in several human cancer cell lines Clin Cancer Res 8 2002 893